Aptus Endosystems is a privately held, well-funded, emerging medical device company that is engaged in the development of next generation minimally invasive endograft devices, delivery systems and fixation technology for the treatment of Abdominal Aortic Aneurysm - the 13th leading cause of death in the United States and the 10th leading cause of death in men over the age of 55.

Profile

Social Media

Aptus Endosystems Company Twitter Account

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

James Reinstein

Chief Operating Officer

Jeff Elkins

Chief Technical Officer

Lee Bolduc

VP - Finance

Dian Georgia

VP - Marketing

Deepak Srikant

VP - Regulatory Affairs

Burt Goodson

Browse more venture capital transactions:

Prev: 12/31/2008: DataSync venture capital transaction
Next: 12/31/2008: ML Healthcare venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary